Hormone & Support
$70
10 vials · 2 mg. Price is for 10 vials.
Long-acting GHRH analog studied in healthy adults for prolonged GH and IGF-I secretion. Not an approved therapy for general use.
Strength
Quantity
Sold in packs of 10 vials. CJC-1295 with DAC 2 mg is priced per pack, not per milligram.
Need help? Contact on Telegram.
Research-use vials sold in packs of 10. Not a medicine and not for human or veterinary use. This catalog is not medical advice. Checkout is Telegram; see terms and privacy.
Intended use: research-use lyophilized peptide. This listing is not a medicine and not for human or veterinary use.
Form: powder in multi-dose vials. Pack of 10 vials at 2 mg.
Storage: keep lyophilized vials cool, dry, and away from sunlight. This page does not provide mixing steps or injection technique.
CJC-1295 is a growth hormone-releasing hormone analog modified for extended activity (often discussed with a drug-affinity complex, DAC). A 2006 healthy-adult study reported prolonged GH and IGF-I stimulation. That is pharmacology, not proof of a safe, effective treatment for a disease. It is not FDA-approved as a marketed GH-axis medicine in the way tesamorelin is.
Educational answers from the research profile. Not treatment advice.
A long-acting GHRH analog studied for prolonged GH and IGF-I secretion. It is not an approved everyday medicine.
No. Both relate to GHRH signaling, but tesamorelin is an FDA-approved product for a specific HIV lipodystrophy indication. CJC-1295 is not that product.
Not established as an FDA-approved therapy for routine use.